• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 16, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Red light therapy device to feature at Myopia Progression in Children Conference 2023

by rhiannon bowman
April 12, 2023
in Local, Myopia, News, Therapies
Reading Time: 3 mins read
A A
Myopia child glasses kid children International Myopia Institute

Optometry Australia has awarded a maximum of 6 CPD hours for the event.

Share on FacebookShare on Twitter

Eyerising International will have its red light therapy device on display at the 2023 Myopia Progression in Children Conference (MPIC), featuring alongside many other new therapeutic interventions at the all-day event taking place in Sydney on 10 June.

MPIC strives to update attendees on the wide range of innovations for the intervention of myopia progression in children available in Australia.

Dr Loren Rose.

In addition to HOYA’s MiYOSMART spectacle lens, and the release of the Stellest lens by EssilorLuxottica late last year, ZEISS will soon release a new lens design aimed at retarding the elongation of the eye with a different peripheral defocus profile.

Explanation and discussion of the different lens designs and research results will be available for review at MPIC.

Event organiser, NSW ophthalmologist Dr Loren Rose, said a comprehensive review of myopia management in Australia will be presented and discussed.

“TGA-approved atropine 0.01% (Eikance) is becoming common practice, as are the slightly higher atropine concentrations available from compound pharmacies, with recent publications demonstrating efficacy to be dose-responsive. A stepwise approach will be discussed to ensure safety and efficacy are achieved for all our patients,” she said.

Another innovation gaining attention is red light therapy.

“The use of red light therapy to control axial growth, refraction and choroidal thickness has been published locally and abroad with dramatic results,” Rose said.

“Adaptation of a red light therapy device initially used for amblyopia treatment overseas is now available for myopic children to be prescribed for two intervals of three minutes daily. The publications demonstrate a substantially reduced axial length progression rate. With more studies on the way, Eyerising International will have its red light therapy device present for discussion and use at MPIC 2023.”

The use of axial length and machines to measure it will also be available on the day to add to the comprehensive review of myopia management in children.

Difficult cases will be discussed by an extended panel. Joining Dr Loren Rose, Dr Trent Sandercoe, and Dr Shanel Sharma, will be two new members, Ms Mariella Coluccio and Ms Homma Ebrahimi, to troubleshoot and provide tips on the day.

Optometry Australia has awarded a maximum of 6 CPD hours for the event.

Click here to register.

More reading

Change to Eikance PI recognises therapeutically-endorsed optometrists in myopia management
Rodenstock MyCon myopia control lens launches in Australia
Aussies report red light therapy shortens axial length in myopia

Related Posts

The optometry school is proposed for James Cook University. Image: EQRoy/Shutterstock.com.

New Queensland optometry school under consideration despite opposition

by Myles Hume
July 16, 2025

A new optometry school – which would be Australia’s eighth – is being proposed in North Queensland, as debate about...

The meeting – running for a third time – welcomed a record 560-plus delegates from 37 countries. Image: APSPOS.

APSPOS 2025 recap; dual Brisbane conference success for Think Business Events

by Staff Writer
July 15, 2025

The 3rd Congress of the Asia-Pacific Strabismus and Paediatric Ophthalmology Society (APSPOS), held in Brisbane from 29 June to 1...

Eye tests are just as important for people with diabetes, and KeepSight helps to facilitate these.  Image: Graphicroyalty/stock.adobe.com.

Report: KeepSight helping save vision of 560,000 Aussies

by Staff Writer
July 15, 2025

A newly released report shows that more than 560,000 Australians with diabetes are reducing their risk of blindness by over...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited